Trial Profile
Study of evaluating time to treatment failure among patients with multiple sclerosis who initiate fingolimod versus teriflunomide in real-world settings: a retrospective US claims study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2020
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 11 May 2018 New trial record
- 27 Apr 2018 Results presented at the 70th Annual Meeting of the American Academy of Neurology